ArticlePediatric cardiology2026
Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation in a Pediatric Patient.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
We report a case of a 12-year-old male patient presenting with paroxysmal atrial fibrillation (AF). Catheter ablation was indicated for symptomatic paroxysmal AF. The procedure was conducted utilizing a cardiac pulsed-field ablation technology (LEAD-PFA, JJET). Lesion creation followed a systematic protocol comprising two sets of four consecutive applications at 1800 V targeting pulmonary veins, plus fifteen applications in inter-pulmonary vein regions and pulmonary venous vestibule. AF was induced during left inferior pulmonary vein ablation and terminated post-procedure. This case represents a documented successful ablation of paroxysmal AF utilizing PFA technology in a pediatric patient. These findings suggest that PFA may constitute a viable and potentially superior therapeutic modality for young patients with AF.
Indexed as
Identifiers
42089929What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.